MYL
is going to be very interesting in the weeks ahead as the "chloroquine theory" gets more testing as a COVID-19 frontline therapeutic. The stock has a Green Light from the Ichimoku Cloud and a breakout set up at $17.50/share.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
